Neuroderm Ltd Ord Sh (NDRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,350 | -15,609 | -8,879 | -7,399 | -1,570 |
| Depreciation Amortization | 11 | 44 | 32 | 20 | 10 |
| Accounts payable and accrued liabilities | 953 | 373 | 12 | 2 | 0 |
| Other Working Capital | 473 | -891 | -3,075 | -1,602 | 0 |
| Other Operating Activity | -250 | 652 | 1,109 | 2,157 | -1,040 |
| Operating Cash Flow | $-4,163 | $-15,431 | $-10,801 | $-6,822 | $-2,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,000 | -14,965 | -14,965 | -23,510 | 0 |
| PPE Investments | -37 | -73 | -55 | -48 | 0 |
| Other Investing Activity | 0 | -54 | 0 | 0 | -23,510 |
| Investing Cash Flow | $-9,037 | $-15,092 | $-15,020 | $-23,558 | $-23,510 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 72,024 | 71,948 | N/A | 0 |
| Financing Cash Flow | $N/A | $72,024 | $71,948 | $N/A | $0 |
| Exchange Rate Effect | N/A | -2,188 | 2,807 | -144 | -960 |
| Beginning Cash Position | 84,735 | 43,238 | 43,238 | 43,238 | 43,230 |
| End Cash Position | 71,701 | 84,735 | 89,482 | 13,011 | 15,420 |
| Net Cash Flow | $-13,034 | $41,497 | $46,244 | $-30,227 | $-27,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,163 | -15,431 | -10,801 | -6,822 | -2,600 |
| Capital Expenditure | -37 | -73 | -55 | -48 | 0 |
| Free Cash Flow | -4,200 | -15,504 | -10,856 | -6,870 | -2,600 |